IJNRD Research Journal

Click Here

WhatsApp editor@ijnrd.org
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Call For Paper

For Authors

Forms / Download

Published Issue Details

Editorial Board

Other IMP Links

Facts & Figure

Impact Factor : 8.76

Issue per Year : 12

Volume Published : 8

Issue Published : 88

Article Submitted : 26375

Article Published : 7533

Total Authors : 19032

Total Reviewer : 980

Total Countries : 150

Indexing Partner

Join RMS/Earn 300


This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title: A Review on Therapeutic Applications of GSK-3 beta Inhibitors
Authors Name: Anu Jayamol Mathew , Aiswarya Suresh , Anu Yousef , Dr. Deepa Jose
Download E-Certificate: Download
Author Reg. ID:
Published Paper Id: IJNRD2203010
Published In: Volume 7 Issue 3, March-2022
Abstract: Abstract : Glycogen synthase kinase 3 beta (GSK-3 beta), which is a serine/threonine kinase was initially identified because of its key role in the regulation of glycogen synthesis. But it is now well-established that GSK-3 performs critical functions in many cellular processes, such as apoptosis, tumor growth, cell invasion, and metastasis. Many human disorders, including cancer, have been linked to abnormal GSK-3 activity, underlining its therapeutic promise as a cancer target. [29]. There is conflicting evidence on the effect of GSK-3 inhibition on cancer cell development due to multiple methods through which GSK-3 may influence carcinogenesis. It can act as a tumor promoter as well as a tumor suppressor in different types of cancers [14]. However, it is found that combination of GSK-3 beta inhibitors with chemotherapeutic agents can significantly reduce the resistance of various tumor cells towards the chemotherapy. In the last few years, many GSK-3 inhibitors have been developed, and some are currently being tested in clinical trials [16]. Indazoles are nitrogen-based heterocyclic chemicals that posses many types of biological activities and representatives of this class of pharmacological agents are widely used as antibacterial, anti-inflammatory, anti-HIV, Antiprotozoal and antimalarial agents. Recent studies are showing promising activity of indazole derivatives as anticancer agents.
Keywords: Glycogen Synthase Kinase 3 Beta (GSK 3 Beta), Indazole Derivatives, GSK 3 Beta Inhibitors, Cancer, Alzheimer’s Disease, Diabetes
Cite Article: "A Review on Therapeutic Applications of GSK-3 beta Inhibitors", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.7, Issue 3, page no.94-103, March-2022, Available :http://www.ijnrd.org/papers/IJNRD2203010.pdf
Downloads: 000114676
ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publication Details: Published Paper ID:IJNRD2203010
Registration ID: 180575
Published In: Volume 7 Issue 3, March-2022
DOI (Digital Object Identifier):
Page No: 94-103
Country: Ernakulam, Kerala, India
Research Area: Pharmacy
Publisher : IJ Publication
Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2203010
Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2203010
Share Article:

Click Here to Download This Article

Article Preview
Click Here to Download This Article

Major Indexing from www.ijnrd.org
Semantic Scholar Microsaoft Academic ORCID Zenodo
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX PUBLON
DRJI SSRN Scribd DocStoc

ISSN Details

ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016

DOI (A digital object identifier)

Providing A digital object identifier by DOI
How to Get DOI? DOI


Open Access License Policy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Creative Commons License This material is Open Knowledge This material is Open Data This material is Open Content

Important Details

Social Media


This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Join RMS/Earn 300